WHO OKs New Genome Editing Registry, Calls For Governance Framework
Executive Summary
A new global registry is being set up to log all research involving genome editing, and there are plans for an online consultation on a governance framework on such research. The Alliance for Regenerative Medicine has welcomed the fact that the new registry will not be as burdensome for therapeutic developers as it originally thought.
You may also be interested in...
WHO's Human Genome Editing Standards Must Not Impact Somatic Cell Research
Concerns have been expressed that efforts by the World Health Organization to establish global standards for the whole spectrum of human genome editing research may inadvertently have a negative impact on companies developing somatic cell therapy medicinal products.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.